Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
NASDAQ:APEN
Price:
10 USD
Market Closed
Updated:
May 18, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
5.9
Current
5.9
Median
2.5
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=5.9
Enterprise Value
/
452.5m
Revenue
76.9m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Apollo Endosurgery Inc
NASDAQ:APEN
|
475.5m USD | 5.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.1B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.1B USD | 18.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.5B USD | 6.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 4.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109B USD | 7.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.2B USD | 4.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59B EUR | 3.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.6B USD | 8.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
51.9B USD | 13.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
373.7B CNY | 9.9 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
5
2-Years Forward
EV/S
4.1
3-Years Forward
EV/S
2.5
You don't have any saved screeners yet
